-
Nick Hardcastle (Peter MacCallum Cancer Centre)06/11/2026, 13:00oral/poster
Objectives
Go to contribution page
Sarcopenia is characterised by loss of skeletal muscle mass and strength, impacting physical performance and quality of life in people with cancer. In neuroendocrine tumours (NETs) it is associated with poor prognosis, but large-scale evidence quantifying its prevalence and changes with disease progression, treatment and nutritional interventions is lacking. Whole-body CTs acquired... -
Chuxin Zhang (UCLouvain)06/11/2026, 13:301oral/poster
Objective
In MR-guided adaptive radiotherapy (MRgRT) for prostate cancer, daily target re-delineation is required to account for inter-fraction anatomical changes, requiring rapid and reliable auto-segmentation. Image-quality degradation from acquisition- and patient-related factors can impair prostate MRI segmentation and may also affect uncertainty estimates. We systematically...
Go to contribution page -
Alessandra Catalano (Fondazione IRCCS Istituto Nazionale dei Tumori, Milano)06/11/2026, 14:00oral/poster
Objective
To develop an explainable artificial intelligence framework integrating radiotherapy dosimetry and quantitative imaging to identify survival-related patient phenotypes and inform personalised dose optimisation in locally advanced non-small cell lung cancer (LA-NSCLC).Methods
Go to contribution page
This multicentre retrospective study included 388 patients treated with curative-intent... -
Alejandro del Pozo Domínguez06/11/2026, 14:30oral/poster
Objective
Go to contribution page
Radiotherapy services routinely generate machine and dosimetric QA data, rarely analysed together. We propose a reproducible five-stage workflow for developing machine-learning models from such data, focusing on the step least often addressed: establishing whether exploitable signal exists, and distinguishing a genuine but weak physical association from useful predictive...
Choose timezone
Your profile timezone: